BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Butowska K, Woziwodzka A, Borowik A, Piosik J. Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies. Materials (Basel) 2021;14:2135. [PMID: 33922291 DOI: 10.3390/ma14092135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shafiei-irannejad V, Rahimkhoei V, Molaparast M, Akbari A. Synthesis and characterization of novel hybrid nanomaterials based on β-cyclodextrine grafted halloysite nanotubes for delivery of doxorubicin to MCF-7 cell line. Journal of Molecular Structure 2022;1262:133004. [DOI: 10.1016/j.molstruc.2022.133004] [Reference Citation Analysis]
2 El-Ghoul Y, Alminderej FM, Alsubaie FM, Alrasheed R, Almousa NH. Recent Advances in Functional Polymer Materials for Energy, Water, and Biomedical Applications: A Review. Polymers (Basel) 2021;13:4327. [PMID: 34960878 DOI: 10.3390/polym13244327] [Reference Citation Analysis]
3 Butowska K, Han X, Gong N, El-mayta R, Haley RM, Xue L, Zhong W, Guo W, Wang K, Mitchell MJ. Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.011] [Reference Citation Analysis]
4 Liu Z, Chen X, Huang Z, Wang H, Cao S, Liu C, Yan H, Lin Q. One-Pot Synthesis of Amphiphilic Biopolymers from Oxidized Alginate and Self-Assembly as a Carrier for Sustained Release of Hydrophobic Drugs. Polymers 2022;14:694. [DOI: 10.3390/polym14040694] [Reference Citation Analysis]
5 Chang D, Ma Y, Xu X, Xie J, Ju S. Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy. Front Bioeng Biotechnol 2021;9:707319. [PMID: 34249894 DOI: 10.3389/fbioe.2021.707319] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]